The Lancet Child & Adolescent Health in conversation with

Safety of multicomponent meningococcal group B vaccine

April 26, 2018 The Lancet
The Lancet Child & Adolescent Health in conversation with
Safety of multicomponent meningococcal group B vaccine
Show Notes

Philip Bryan joins The Lancet Child & Adolescent Health to discuss the safety of multicomponent meningococcal group B vaccine (4CMenB) in the UK’s infant immunisation programme.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv